Agios Pharmaceuticals | Resultado Líquido



Net Income Alterar Data
AbbVie USD -22000000 1.58B 2024-12
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
Amgen USD 627M 2.2B 2024-12
Arrowhead Research USD -173085000 2.55M 2024-12
Astellas Pharma JPY -97660000000 133.57B 2024-12
AstraZeneca USD 1.5B 71M 2024-12
Bayer EUR -335000000 3.85B 2024-12
Biogen USD 266.7M 121.8M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Daiichi Sankyo JPY 61.93B 635M 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Exelixis USD 139.86M 21.89M 2025-01
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 414M 472M 2024-12
Incyte USD 201.21M 94.76M 2024-12
Ionis Pharmaceuticals USD -104349000 36.13M 2024-12
Merck USD 3.74B 586M 2024-12
Moderna USD -1120000000 1.13B 2024-12
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 410M 4.06B 2024-12
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Agios Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.